The human UTY gene encodes a novel HLA-B8-restricted H-Y antigen

Journal of Immunology

Volumn 164, Issue 5, 2000, Pages 2807-2814

  Warren, Edus H ^a,b   Gavin, Marc A ^a   Simpson, Elizabeth ^c   Chandler, Phillip ^c   Page, David C ^d   Disteche, Christine ^b   Stankey, Kimberly A ^a   Greenberg, Philip D ^a,b   Riddell, Stanley R ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE; EPITOPE; GAMMA INTERFERON; HLA B8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN; RNA; SYNTHETIC PEPTIDE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ARTICLE; BONE MARROW TRANSPLANTATION; GENE LOCUS; GRAFT REJECTION; HLA SYSTEM; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; NUCLEOTIDE SEQUENCE; ORGAN TRANSPLANTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; Y CHROMOSOME;

EID: 0034161723     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.5.2807     Document Type: Article

References (48)

1. Eichwald, E. J., and C. R. Silmser. 1955. Untitled. Transplant. Bull. 2:148.
2. Goulmy, E., A. Termijtelen, B. A. Bradley, and J. J. van Rood. 1977. Y-antigen killing by T cells of women is restricted by HLA. Nature 266:544.
3. Voogt, P. J., W. E. Fibbe, W. A. Marijt, E. Goulmy, W. F. Veenhof, M. Hamilton, A. Brand, F. E. Zwann, R. Willemze, J. J. van Rood, et al. 1990. Rejection of bone-marrow graft by recipient-derived cytotoxic T lymphocytes against minor histocompatibility antigens. Lancet 335:131.
4. Gordon, R. D., E. Simpson, and L. E. Samelson. 1975. In vitro cell-mediated immune responses to the male specific (H-Y) antigen in mice. J. Exp. Med. 142:1108.
5. Gordon, R. D., and E. Simpson. 1977. Immune-response gene control of cytotoxic T-cell responses to H-Y. Transplant. Proc. 9:885.
6. Goulmy, E., A. Termijtelen, B. A. Bradley, and J. J. van Rood. 1976. Alloimmunity to human H-Y. Lancet 2:1206.
7. Scott, D. M., I. E. Ehrmann, P. S. Ellis, C. E. Bishop, A. I. Agulnik, E. Simpson, and M. J. Mitchell. 1995. Identification of a mouse male-specific transplantation antigen, H-Y. Nature 376:695.
8. Simpson, E., D. Scott, and P. Chandler. 1997. The male-specific histocompatibility antigen, H-Y: a history of transplantation, immune response genes, sex determination and expression cloning. Annu. Rev. Immunol. 15:39.
9. Greenfield, A., D. Scott, D. Pennisi, I. Ehrmann, P. Ellis, L. Cooper, E. Simpson, and P. Koopman. 1996. An H-YDb epitope is encoded by a novel mouse Y chromosome gene. Nat. Genet. 14:474.
10. Meadows, L., W. Wang, J. M. den Haan, E. Blokland, C. Reinhardus, J. W. Drijfhout, J. Shabanowitz, R. Pierce, A. I. Agulnik, C. E. Bishop, et al. 1997. The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition. Immunity 6:273.
11. Wang, W., L. R. Meadows, J. M. den Haan, N. E. Sherman, Y. Chen, E. Blokland, J. Shabanowitz, A. I. Agulnik, R. C. Hendrickson, C. E. Bishop, et al. 1995. Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein. Science 269:1588.
12. Warren, E. H., P. D. Greenberg, and S. R. Riddell. 1998. Cytotoxic T-lymphocyte-defined human minor histocompatibility antigens with a restricted tissue distribution. Blood 91:2197.
13. De Bueger, M., A. Bakker, J. J. Van Rood, F. Van der Woude, and E. Goulmy. 1992. Tissue distribution of human minor histocompatibility antigens: ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens. J. Immunol. 149:1788.
14. Brodie, S. J., D. A. Lewinsohn, B. K. Patterson, D. Jiyamapa, J. Krieger, L. Corey, P. D. Greenberg, and S. R. Riddell. 1999. In vivo migration and function of transferred HIV-1-specific cytotoxic T cells. Nat. Med. 5:34.
15. Goulmy, E., A. van Leeuwen, E. Blokland, E. S. Sachs, and J. P. Geraedts. 1983. The recognition of abnormal sex chromosome constitution by HLA- restricted anti-H-Y cytotoxic T cells and antibody. Immunogenetics 17:523.
16. Simpson, E., P. Chandler, E. Goulmy, C. M. Disteche, M. A. Ferguson-Smith, and D. C. Page. 1987. Separation of the genetic loci for the H-Y antigen and for testis determination on human Y chromosome. Nature 326:876.
17. O'Reilly, A. J., N. A. Affara, E. Simpson, P. Chandler, E. Goulmy, and M. A. Ferguson-Smith. 1992. A molecular deletion map of the Y chromosome long arm defining X and autosomal homologous regions and the localization of the HYA locus to the proximal region of the Yq euchromatin. Hum. Mol. Genet. 1:379.
18. Vollrath, D., S. Foote, A. Hilton, L. G. Brown, P. Beer-Romero, J. S. Bogan, and D. C. Page. 1992. The human Y chromosome: a 43-interval map based on naturally occurring deletions. Science 258:52.
19. Riddell, S. R., M. Rabin, A. P. Geballe, W. J. Britt, and P. D. Greenberg. 1991. Class I MHC-restricted cytotoxic T lymphocyte recognition of cells infected with human cytomegalovirus does not require endogenous viral gene expression. J. Immunol. 146:2795.
20. Gartner, S., and H. S. Kaplan. 1980. Long-term culture of human bone marrow cells. Proc. Natl. Acad. Sci. USA 77:4756.
21. Roecklein, B. A., and B. Torok-Storb. 1995. Functionally distinct human marrow stromal cell lines immortalized by transduction with the human papilloma virus E6/E7 genes. Blood 85:997.
22. Austgulen, R., T. Espevik, J. Hammerstrom, and J. Nissen-Meyer. 1986. Role of monocyte cytotoxic factor in cytolysis of actinomycin D-treated WEHI 164 cells mediated by freshly isolated human adherent mononuclear blood cells. Cancer Res. 46:4566.
23. Lahn, B. T., and D. C. Page. 1997. Functional coherence of the human Y chromosome. Science 278:675.
24. Salido, E. C., P. H. Yen, K. Koprivnikar, L. C. Yu, and L. J. Shapiro. 1992. The human enamel protein gene amelogenin is expressed from both the X and the Y chromosomes. Am. J. Hum. Genet. 50:303.
25. Parker, K. C., M. A. Bednarek, and J. E. Coligan. 1994. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peplide side-chains. J. Imnmnol. 152:163.
26. Goulmy, E. 1996. Human minor histocompatibility antigens. Curr. Opin. Immunol. 8:75.
27. Vogt, P. H., N. Affara, P. Davey, M. Hammer, M. A. Jobling, Y. F. Lau, M. Mitchell, W. Schempp, C. Tyler-Smith, G. Williams, et al. 1997. Report of the Third International Workshop on Y Chromosome Mapping 1997. Cytogenet. Cell Genet. 79:1.
28. Lahn, B. T., and D. C. Page. 1999. Four evolutionary strata on the human X chromosome. Science 286:964.
29. Gale, R. P., M. M. Bortin, D. W. van Bekkum, J. C. Biggs, K. A. Dicke, E. Gluckman, R. A. Good, R. G. Hoffmann, H. E. Kay, J. H. Kersey, et al. 1987. Risk factors for acute graft-versus-host disease. Br. J. Haematol. 67:397.
30. Storb, R., R. L. Prentice, and E. D. Thomas. 1977. Treatment of aplastic anemia by marrow transplantation from HLA identical siblings: prognostic factors associated with graft versus host disease and survival. J. Clin. Invest. 59:625.
31. Weisdorf, D., R. Hakke, B. Blazar, W. Miller, P. McGlave, N. Ramsay, J. Kersey, and A. Filipovich. 1991. Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation. Transplantation 51:1197.
32. Nash, R. A., M. S. Pepe, R. Storb, G. Longton, M. Pettinger, C. Anasetti, F. R. Appelbaum, R. A. Bowden, H. J. Deeg, K. Doney, et al. 1992. Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate. Blood 80:1838.
33. Zwaan, F. E., J. Hermans, A. Gratwohl, for the European Leukemia Working Party (EBMT-LWP). 1989. The influence of donor-recipient sex mismatching on the outcome of allogeneic BMT in leukemia. Bone Marrow Transplant. 4 (Suppl. 2):8.
34. Okunewick, J., D. L. Kociban, L. L. Machen, and M. J. Buffo. 1993. Effect of donor and recipient gender disparities on fatal graft-vs.-host disease in a mouse model for major histocompatibility complex-matched unrelated-donor bone marrow transplantation. Exp. Hematol. 21:1570.
35. Wettstein, P. J. 1986. Immunodominance in the T cell response to multiple non-H-2 histocompatibility antigens. III. Single histocompatibility antigens dominate the male antigen. J. Immunol. 137:2073.
36. Pion, S., P. Fontaine, M. Desaulniers, J. Jutras, J. G. Filep, and C. Perreault. 1997. On the mechanisms of immunodominance in cytotoxic T lymphocyte responses to minor histocompatibility antigens. Eur. J. Immunol. 27:421.
37. Pion, S., G. J. Christianson, P. Fontaine, D. C. Roopenian, and C. Perreault. 1999. Shaping the repertoire of cytotoxic T-lymphocyte responses: explanation for the immunodominance effect whereby cytotoxic T lymphocytes specific for immunodommanl antigens prevent recognition of nondominant antigens. Blood 93: 952.
38. Rufer, N., E. Wolpert, C. Helg, J. M. Tiercy, A. Gratwohl, B. Chapuis, M. Jeannet, E. Goulmy, and E. Roosnek. 1998. HA-1 and the SMCY-derived peptide FIDSYICQV (H-Y) are immunodominant minor histocompatibility antigens after bone marrow transplantation. Transplantation 66:910.
39. Ogg, G. S., X. Jin, S. Bonhoeffer, P. R. Dunbar, M. A. Nowak, S. Monard, J. P. Segal, Y. Cao, S. L. Rowland-Jones, V. Cerundolo, et al. 1998. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 279:2103.
40. Yee, C., P. A. Savage, P. P. Lee, M. M. Davis, and P. D. Greenberg. 1999. Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers. J. Immunol. 162:2227.
41. Mutis, T., G. Gillespie, E. Schrama, J. H. Falkenburg, P. Moss, and E. Goulmy. 1999. Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease. Nat. Med. 5:839.
42. Goulmy, E. 1997. Human minor histocompatibility antigens: new concepts for marrow transplantation and adoptive immunotherapy. Immunol. Rev. 157:125.
43. Mutis, T., R. Verdijk, E. Schrama, B. Esendam, A. Brand, and E. Goulmy. 1999. Feasibility of immunotherapy of relapsed leukemia with ex vivo-generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigens. Blood 93:2336.
44. Dolstra, H., H. Fredrix, F. Preijers, E. Goulmy, C. G. Figdor, T. M. de Witte, and E. van de Wiel-van Kemenade. 1997. Recognition of a B cell leukemia-associated minor histocompatibility antigen by CTL. J. Immunol. 158:560.
45. Dolstra, H., H. Fredrix, F. Maas, P. G. Coulie, F. Brasseur, E. Mensink, G. J. Adema, T. M. de Witte, C. G. Figdor, and E. van de Wiel-van Kemenade. 1999. A human minor histocompatibility antigen specific for B cell acute lymphoblastic leukemia. J. Exp. Med. 189:301.
46. + minor histocompatibility antigen-specific cytotoxic T lymphocyte clones eliminate human acute myeloid leukemia stem cells. Proc. Natl. Acad. Sci. USA 6:8639.
47. Van den Eynde, B. J., and P. van der Bruggen. 1997. T cell defined tumor antigens. Curr. Opin. Immunol. 9:684.
48. Vonderheide, R. H., W. C. Hahn, J. L. Schultze, and L. M. Nadler. 1999. The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes. Immunity 10:673.